Frequency and risk factors of metabolic associated fatty liver disease among medical students in Egypt

Abstract Metabolic (dysfunction) associated fatty liver disease (MAFLD) is a growing global concern. This study assessed the frequency of hepatic steatosis and MAFLD, alongside their associated risk factors, among medical students at Suez University, Egypt. A cross-sectional study was conducted from...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Mohamed M. Elhoseeny, Fatma Rageh, Samar M. Rezk, Amira A. A. Othman
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-04-01
Subjects:	FibroScan® InBody 270 MAFLD NAFLD Steatosis Transient elastography
Online Access:	https://doi.org/10.1038/s41598-025-95753-w

Similar Items

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)

Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Children with Overweight and Obesity by Transient Elastography
by: Mohamed Fajrudheen, et al.
Published: (2025-03-01)

Fibrosis Progression in Patients with Budd–Chiari Syndrome and Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Long-Term Study Using Transient Elastography
by: Martin Rössle, et al.
Published: (2024-02-01)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
by: Zahra Safari, et al.
Published: (2023-05-01)

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
by: Leire Pérez-Latorre, et al.
Published: (2018-04-01)

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
by: Giovanna Cuomo, et al.
Published: (2023-05-01)

Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese population
by: Hanying Liu, et al.
Published: (2022-07-01)

Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study
by: Mohamed M. Elhoseeny, et al.
Published: (2024-07-01)

Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis
by: Mitchell Patrick Wilson, et al.
Published: (2025-06-01)

Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience
by: Stephan Baumeler, et al.
Published: (2019-04-01)

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database
by: Naim Alkhouri, et al.
Published: (2022-07-01)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
by: Abo-Amer YEE, et al.
Published: (2020-03-01)

Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
by: Luca Rinaldi, et al.
Published: (2023-08-01)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
by: Ming-Lun Yeh, et al.
Published: (2023-10-01)

Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation
by: Mohsen S. Elalfy, MD, PhD, et al.
Published: (2013-01-01)

Innovative Elastography Measuring Cap for Ex Vivo Liver Condition Assessment: Numerical and Preclinical Studies in a Porcine Model
by: Dariusz Pyka, et al.
Published: (2025-01-01)

Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis
by: Stefano Ciardullo, et al.
Published: (2022-01-01)

Liver biopsy for histological assessment - the case against
by: Sanai Faisal, et al.
Published: (2010-01-01)

Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease in American adults: a population-based analysis
by: Yilian Xie, et al.
Published: (2023-05-01)

Dynamic Changes in Liver Stiffness in Patients with Chronic Hepatitis B Undergoing Antiviral Therapy
by: Alin Lazar, et al.
Published: (2022-10-01)

Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population
by: Nsumbu JB, et al.
Published: (2025-07-01)

Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes
by: Yilian Xie, et al.
Published: (2022-08-01)

Multiparametric Quantitative Ultrasound as a Potential Imaging Biomarker for Noninvasive Detection of Nonalcoholic Steatohepatitis: A Clinical Feasibility Study
by: Trina Chattopadhyay, et al.
Published: (2025-09-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)

Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease
by: Karolina Grąt, et al.
Published: (2020-08-01)

Identification of high-risk subjects in nonalcoholic fatty liver disease
by: Christiane Stern, et al.
Published: (2023-02-01)

Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children
by: Meng-Yuan Hu, et al.
Published: (2025-02-01)

Correlación entre los hallazgos tomográficos y los resultados obtenidos por FibroScan® para la detección de esteatosis hepática.
by: Pablo Aure Celli, et al.
Published: (2024-12-01)

Rendimiento diagnóstico del FibroScan en un centro de enfermedades hepáticas en Bogotá durante el 2019 al 2022
by: Diana del Pilar Torres Pabón, et al.
Published: (2024-03-01)

Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India
by: Bharam Bhargava, et al.
Published: (2025-03-01)

Biomarcadores para fibrosis hepática, avances, ventajas y desventajas
by: A. Cequera, et al.
Published: (2014-07-01)

2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis
by: Ahmed M. Osman, et al.
Published: (2020-03-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
by: Xinyu Yang, et al.
Published: (2021-03-01)

Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01)

A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
by: Hira Hanif, et al.
Published: (2020-10-01)

Factors Associated with the Severity of Findings on Hepatic Transient Elastography among Persons with Type 2 Diabetes and Fatty Liver
by: Joseph Noel Fernando, et al.
Published: (2019-11-01)

Factors associated with obtaining lower IQR-CAP values in the detection of hepatic steatosis by transient elastography
by: Iván López-Mendez, et al.
Published: (2025-01-01)

Clinical and Anamnestic Features of Hepatic Steatosis in Children
by: N.Yu. Zavgorodnia, et al.
Published: (2015-11-01)